133 results
Page 3 of 7
8-K
EX-10.1
3ztt7dov
26 Apr 22
Departure of Directors or Certain Officers
6:51am
8-K
b0t0 no7l0
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-10.1
wv1ciyis
1 Feb 22
Kiora Pharmaceuticals Appoints Erin Parsons to its Board of Directors; Stephen From to Retire from Board
6:45am
8-K
EX-2.1
etnhnh2vmxk6s5
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-99.1
vffujeu73zuvun
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-10.1
t4zytptta1rl3 x4xi
26 Oct 21
EyeGate adds Bayon Therapeutics’ portfolio of vision-restoring small molecules to its development pipeline
7:00am
8-K
EX-99.1
ir9mrts
14 Sep 21
Regulation FD Disclosure
4:20pm
424B5
myerr9muta45wn0o8wu
11 Aug 21
Prospectus supplement for primary offering
6:56am
8-K
EX-10.2
6vko1j
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am
8-K
EX-10.1
j3f lybbg
10 Aug 21
EyeGate Announces $10.75 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
6:55am